These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
486 related items for PubMed ID: 17085937
1. Interaction of plasma homocysteine and thyroid hormone concentrations in the pathogenesis of the slow coronary flow phenomenon. Evrengul H, Tanriverdi H, Enli Y, Kuru O, Seleci D, Bastemir M, Kilic A, Kaftan A, Kilic M. Cardiology; 2007; 108(3):186-92. PubMed ID: 17085937 [Abstract] [Full Text] [Related]
2. Elevated homocysteine levels in patients with slow coronary flow: relationship with Helicobacter pylori infection. Evrengul H, Tanriverdi H, Kuru O, Enli Y, Yuksel D, Kilic A, Kaftan A, Kirac S, Kilic M. Helicobacter; 2007 Aug; 12(4):298-305. PubMed ID: 17669101 [Abstract] [Full Text] [Related]
4. Effect of homocysteine-induced oxidative stress on endothelial function in coronary slow-flow. Tanriverdi H, Evrengul H, Enli Y, Kuru O, Seleci D, Tanriverdi S, Tuzun N, Kaftan HA, Karabulut N. Cardiology; 2007 Aug; 107(4):313-20. PubMed ID: 17264512 [Abstract] [Full Text] [Related]
6. Impaired coronary blood flow may be related to elevated homocysteine levels in patients with metabolic syndrome. Alihanoglu YI, Yildiz BS, Özcan EE, Kilic ID, Kuru DS, Taskoylu O, Tanriverdi H, Kaftan HA, Evrengul H. Wien Klin Wochenschr; 2015 Nov; 127(21-22):864-870. PubMed ID: 26377176 [Abstract] [Full Text] [Related]
7. The role of adrenergic activity in slow coronary flow and its relationship to TIMI frame count. Yazici M, Demircan S, Durna K, Sahin M. Angiology; 2007 Nov; 58(4):393-400. PubMed ID: 17652227 [Abstract] [Full Text] [Related]
8. Elevated plasma homocysteine level in slow coronary flow. Barutcu I, Sezgin AT, Sezgin N, Gullu H, Esen AM, Topal E, Ozdemir R. Int J Cardiol; 2005 May 11; 101(1):143-5. PubMed ID: 15860399 [Abstract] [Full Text] [Related]
9. The effects of endothelial dysfunction and inflammation on slow coronary flow. Arı H, Arı S, Erdoğan E, Tiryakioğlu O, Huysal K, Koca V, Bozat T. Turk Kardiyol Dern Ars; 2010 Jul 11; 38(5):327-33. PubMed ID: 21200102 [Abstract] [Full Text] [Related]
10. Increased plasma soluble adhesion molecules; ICAM-1, VCAM-1, and E-selectin levels in patients with slow coronary flow. Turhan H, Saydam GS, Erbay AR, Ayaz S, Yasar AS, Aksoy Y, Basar N, Yetkin E. Int J Cardiol; 2006 Apr 04; 108(2):224-30. PubMed ID: 16002164 [Abstract] [Full Text] [Related]
12. Carotid intima-media thickness in coronary slow flow: relationship with plasma homocysteine levels. Tanriverdi H, Evrengul H, Tanriverdi S, Kuru O, Seleci D, Enli Y, Kaftan A, Kilic M. Coron Artery Dis; 2006 May 04; 17(4):331-7. PubMed ID: 16707955 [Abstract] [Full Text] [Related]
13. Clinical and coronary angiographic characteristics of patients with coronary slow flow. Yilmaz H, Demir I, Uyar Z. Acta Cardiol; 2008 Oct 04; 63(5):579-84. PubMed ID: 19014000 [Abstract] [Full Text] [Related]
15. Plasma homocysteine is associated with ischemic findings without organic stenosis in patients with slow coronary flow. Yurtdaş M, Özcan IT, Seyis AS, Çamsarı A, Ciçek D. J Cardiol; 2013 Feb 04; 61(2):138-43. PubMed ID: 23159204 [Abstract] [Full Text] [Related]
16. Increased neopterin levels and its association with angiographic variables in patients with slow coronary flow: an observational study. Varol E, Gülcan M, Aylak F, Ozaydın M, Sütçü R, Erdoğan D, Doğan A. Anadolu Kardiyol Derg; 2011 Dec 04; 11(8):692-7. PubMed ID: 22088857 [Abstract] [Full Text] [Related]